JP Patent

JP2014534215A — パゾパニブ製剤

Assigned to GlaxoSmithKline Intellectual Property Development Ltd · Expires 2014-12-18 · 11y expired

What this patent protects

水性ビヒクルを用いた再構成に適した5-[[4-[(2,3-ジメチル-2H-インダゾール-6-イル)メチルアミノ]-2-ピリミジニル]アミノ]-2-メチルベンゼンスルホンアミドまたはその製薬上許容可能な塩の顆粒剤、および関連する経口懸濁剤。【選択図】図１

USPTO Abstract

水性ビヒクルを用いた再構成に適した5-[[4-[(2,3-ジメチル-2H-インダゾール-6-イル)メチルアミノ]-2-ピリミジニル]アミノ]-2-メチルベンゼンスルホンアミドまたはその製薬上許容可能な塩の顆粒剤、および関連する経口懸濁剤。【選択図】図１

Drugs covered by this patent

Patent Metadata

Patent number
JP2014534215A
Jurisdiction
JP
Classification
—
Expires
2014-12-18
Drug substance claim
No
Drug product claim
No
Assignee
GlaxoSmithKline Intellectual Property Development Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.